APO Research
Talk to an analyst

APO RESEARCH · REPORT

C13 Stable Isotope Labeled Biomolecules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global C13 Stable Isotope Labeled Biomolecules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchC13 Stable Isotope Labeled Biomolecules Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal C13 Stable Isotope Labeled Biomolecules Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal C13 Stable Isotope Labeled Biomolecules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C13 Stable Isotope Labeled Biomolecules Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal C13 Stable Isotope Labeled Biomolecules Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global C13 Stable Isotope Labeled Biomolecules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for C13 Stable Isotope Labeled Biomolecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for C13 Stable Isotope Labeled Biomolecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for C13 Stable Isotope Labeled Biomolecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for C13 Stable Isotope Labeled Biomolecules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of C13 Stable Isotope Labeled Biomolecules include Cambridge Isotope Laboratories, Icon Isotopes, IsoLife BV, LGC Standards, Medical Isotopes, Omicron Biochemicals, Sigma-Aldrich, Toronto Research Chemicals and WITEGA Laboratorien, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global C13 Stable Isotope Labeled Biomolecules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of C13 Stable Isotope Labeled Biomolecules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents C13 Stable Isotope Labeled Biomolecules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the C13 Stable Isotope Labeled Biomolecules market size, projected growth trends, production technologies, key applications, and end-use industries.

C13 Stable Isotope Labeled Biomolecules Segment by Company

Cambridge Isotope Laboratories

Icon Isotopes

IsoLife BV

LGC Standards

Medical Isotopes

Omicron Biochemicals

Sigma-Aldrich

Toronto Research Chemicals

WITEGA Laboratorien

Thermo Fisher Scientific

C13 Stable Isotope Labeled Biomolecules Segment by Type

Medical C13 Stable Isotope Labeled Biomolecules

Others

C13 Stable Isotope Labeled Biomolecules Segment by Application

Medical

Scientific Research

Industrial

Others

C13 Stable Isotope Labeled Biomolecules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C13 Stable Isotope Labeled Biomolecules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C13 Stable Isotope Labeled Biomolecules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C13 Stable Isotope Labeled Biomolecules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the C13 Stable Isotope Labeled Biomolecules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of C13 Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of C13 Stable Isotope Labeled Biomolecules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of C13 Stable Isotope Labeled Biomolecules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. C13 Stable Isotope Labeled Biomolecules Industry Trends Table 2. C13 Stable Isotope Labeled Biomolecules Industry Drivers Table 3. C13 Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges Table 4. C13 Stable Isotope Labeled Biomolecules Industry Restraints Table 5. Global C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global C13 Stable Isotope Labeled Biomolecules Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Manufacturers Table 9. Global C13 Stable Isotope Labeled Biomolecules Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global C13 Stable Isotope Labeled Biomolecules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global C13 Stable Isotope Labeled Biomolecules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global C13 Stable Isotope Labeled Biomolecules Manufacturers, Product Type & Application Table 13. Global C13 Stable Isotope Labeled Biomolecules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global C13 Stable Isotope Labeled Biomolecules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Medical C13 Stable Isotope Labeled Biomolecules Table 17. Major Manufacturers of Others Table 18. Global C13 Stable Isotope Labeled Biomolecules Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 19. Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2026) & (k tons) Table 20. Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2027-2032) & (k tons) Table 21. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2026) Table 22. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2027-2032) Table 23. Global C13 Stable Isotope Labeled Biomolecules Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 24. Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2026) & (k tons) Table 25. Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2027-2032) & (k tons) Table 26. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2026) Table 27. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Medical Table 29. Major Manufacturers of Scientific Research Table 30. Major Manufacturers of Industrial Table 31. Major Manufacturers of Others Table 32. Global C13 Stable Isotope Labeled Biomolecules Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 33. Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2026) & (k tons) Table 34. Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2027-2032) & (k tons) Table 35. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2026) Table 36. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2027-2032) Table 37. Global C13 Stable Isotope Labeled Biomolecules Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 38. Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2026) & (k tons) Table 39. Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2027-2032) & (k tons) Table 40. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2026) Table 41. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2027-2032) Table 42. Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 43. Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2021-2026) & (k tons) Table 44. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2021-2026) Table 45. Global C13 Stable Isotope Labeled Biomolecules Sales Forecasted by Region (2027-2032) & (k tons) Table 46. Global C13 Stable Isotope Labeled Biomolecules Sales Forecasted Market Share by Region (2027-2032) Table 47. North America C13 Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 48. North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (k tons) Table 49. North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (k tons) Table 50. Europe C13 Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 51. Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (k tons) Table 52. Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (k tons) Table 53. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 54. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (k tons) Table 55. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (k tons) Table 56. South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 57. South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (k tons) Table 58. South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (k tons) Table 59. Global C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global C13 Stable Isotope Labeled Biomolecules Revenue by Region (2021-2026) & (US$ Million) Table 61. Global C13 Stable Isotope Labeled Biomolecules Revenue by Region (2027-2032) & (US$ Million) Table 62. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2021-2026) Table 63. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2027-2032) Table 64. Cambridge Isotope Laboratories Company Information Table 65. Cambridge Isotope Laboratories Business Overview Table 66. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 68. Cambridge Isotope Laboratories Recent Development Table 69. Icon Isotopes Company Information Table 70. Icon Isotopes Business Overview Table 71. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 73. Icon Isotopes Recent Development Table 74. IsoLife BV Company Information Table 75. IsoLife BV Business Overview Table 76. IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. IsoLife BV C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 78. IsoLife BV Recent Development Table 79. LGC Standards Company Information Table 80. LGC Standards Business Overview Table 81. LGC Standards C13 Stable Isotope Labeled Biomolecules Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. LGC Standards C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 83. LGC Standards Recent Development Table 84. Medical Isotopes Company Information Table 85. Medical Isotopes Business Overview Table 86. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 88. Medical Isotopes Recent Development Table 89. Omicron Biochemicals Company Information Table 90. Omicron Biochemicals Business Overview Table 91. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 93. Omicron Biochemicals Recent Development Table 94. Sigma-Aldrich Company Information Table 95. Sigma-Aldrich Business Overview Table 96. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 98. Sigma-Aldrich Recent Development Table 99. Toronto Research Chemicals Company Information Table 100. Toronto Research Chemicals Business Overview Table 101. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 103. Toronto Research Chemicals Recent Development Table 104. WITEGA Laboratorien Company Information Table 105. WITEGA Laboratorien Business Overview Table 106. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 108. WITEGA Laboratorien Recent Development Table 109. Thermo Fisher Scientific Company Information Table 110. Thermo Fisher Scientific Business Overview Table 111. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 113. Thermo Fisher Scientific Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. C13 Stable Isotope Labeled Biomolecules Distributors List Table 117. C13 Stable Isotope Labeled Biomolecules Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. C13 Stable Isotope Labeled Biomolecules Product Image Figure 2. Global C13 Stable Isotope Labeled Biomolecules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C13 Stable Isotope Labeled Biomolecules Market Size (2021-2032) & (US$ Million) Figure 4. Global C13 Stable Isotope Labeled Biomolecules Sales (2021-2032) & (k tons) Figure 5. Global C13 Stable Isotope Labeled Biomolecules Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 C13 Stable Isotope Labeled Biomolecules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Medical C13 Stable Isotope Labeled Biomolecules Image Figure 9. Others Image Figure 10. Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 11. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2032) Figure 13. Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 14. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2032) Figure 16. Medical Image Figure 17. Scientific Research Image Figure 18. Industrial Image Figure 19. Others Image Figure 20. Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 21. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2032) Figure 23. Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 24. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2032) Figure 26. North America C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 27. North America C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2021-2032) Figure 28. U.S. C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 29. Canada C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 30. Mexico C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 31. Europe C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 32. Europe C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2021-2032) Figure 33. Germany C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 34. France C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 35. U.K. C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Italy C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 37. Netherlands C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 38. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 39. Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2021-2032) Figure 40. China C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 41. Japan C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 42. South Korea C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 43. Southeast Asia C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 44. India C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 45. Australia C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 46. South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 47. South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Market Share by Country (2021-2032) Figure 48. Brazil C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 49. South Africa C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 50. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 51. Turkey C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 52. Argentina C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 53. UAE C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Egypt C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Chile C13 Stable Isotope Labeled Biomolecules Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Global C13 Stable Isotope Labeled Biomolecules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Figure 59. North America C13 Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Figure 61. Europe C13 Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific C13 Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. C13 Stable Isotope Labeled Biomolecules Value Chain Figure 67. Manufacturing Cost Structure Figure 68. C13 Stable Isotope Labeled Biomolecules Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Medical C13 Stable Isotope Labeled Biomolecules
  • Others
Applications
  • Medical
  • Scientific Research
  • Industrial
  • Others
Companies covered
  • Cambridge Isotope Laboratories
  • Icon Isotopes
  • IsoLife BV
  • LGC Standards
  • Medical Isotopes
  • Omicron Biochemicals
  • Sigma-Aldrich
  • Toronto Research Chemicals
  • WITEGA Laboratorien
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global C13 Stable Isotope Labeled Biomolecules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global C13 Stable Isotope Labeled Biomolecules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global C13 Stable Isotope Labeled Biomolecules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global C13 Stable Isotope Labeled Biomolecules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global C13 Stable Isotope Labeled Biomolecules Market Dynamics
  1. 2.1 C13 Stable Isotope Labeled Biomolecules Industry Trends
  2. 2.2 C13 Stable Isotope Labeled Biomolecules Industry Drivers
  3. 2.3 C13 Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges
  4. 2.4 C13 Stable Isotope Labeled Biomolecules Industry Restraints
3 C13 Stable Isotope Labeled Biomolecules Market by Manufacturers
  1. 3.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Manufacturers (2021-2026)
  3. 3.3 Global C13 Stable Isotope Labeled Biomolecules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global C13 Stable Isotope Labeled Biomolecules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global C13 Stable Isotope Labeled Biomolecules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global C13 Stable Isotope Labeled Biomolecules Manufacturers, Product Type & Application
  7. 3.7 Global C13 Stable Isotope Labeled Biomolecules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global C13 Stable Isotope Labeled Biomolecules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 C13 Stable Isotope Labeled Biomolecules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 C13 Stable Isotope Labeled Biomolecules Tier 1, Tier 2, and Tier 3
4 C13 Stable Isotope Labeled Biomolecules Market by Type
  1. 4.1 C13 Stable Isotope Labeled Biomolecules Type Introduction
  2. 4.1.1 Medical C13 Stable Isotope Labeled Biomolecules
  3. 4.1.2 Others
  4. 4.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Type
  5. 4.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2032)
  7. 4.2.3 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2032)
  8. 4.3 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type
  9. 4.3.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2032)
  11. 4.3.3 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2032)
5 C13 Stable Isotope Labeled Biomolecules Market by Application
  1. 5.1 C13 Stable Isotope Labeled Biomolecules Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Scientific Research
  4. 5.1.3 Industrial
  5. 5.1.4 Others
  6. 5.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Application
  7. 5.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2032)
  9. 5.2.3 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2032)
  10. 5.3 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application
  11. 5.3.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2032)
  13. 5.3.3 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2032)
6 Global C13 Stable Isotope Labeled Biomolecules Sales by Region
  1. 6.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2021-2032)
  3. 6.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2021-2026)
  4. 6.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America C13 Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe C13 Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region
  1. 7.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region
  2. 7.1.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region (2021-2026)
  4. 7.1.3 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region (2027-2032)
  5. 7.1.4 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032)
  8. 7.2.2 North America C13 Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032)
  11. 7.3.2 Europe C13 Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific C13 Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Cambridge Isotope Laboratories
  2. 8.1.1 Cambridge Isotope Laboratories Company Information
  3. 8.1.2 Cambridge Isotope Laboratories Business Overview
  4. 8.1.3 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product Portfolio
  6. 8.1.5 Cambridge Isotope Laboratories Recent Developments
  7. 8.2 Icon Isotopes
  8. 8.2.1 Icon Isotopes Company Information
  9. 8.2.2 Icon Isotopes Business Overview
  10. 8.2.3 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio
  12. 8.2.5 Icon Isotopes Recent Developments
  13. 8.3 IsoLife BV
  14. 8.3.1 IsoLife BV Company Information
  15. 8.3.2 IsoLife BV Business Overview
  16. 8.3.3 IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 IsoLife BV C13 Stable Isotope Labeled Biomolecules Product Portfolio
  18. 8.3.5 IsoLife BV Recent Developments
  19. 8.4 LGC Standards
  20. 8.4.1 LGC Standards Company Information
  21. 8.4.2 LGC Standards Business Overview
  22. 8.4.3 LGC Standards C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 LGC Standards C13 Stable Isotope Labeled Biomolecules Product Portfolio
  24. 8.4.5 LGC Standards Recent Developments
  25. 8.5 Medical Isotopes
  26. 8.5.1 Medical Isotopes Company Information
  27. 8.5.2 Medical Isotopes Business Overview
  28. 8.5.3 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio
  30. 8.5.5 Medical Isotopes Recent Developments
  31. 8.6 Omicron Biochemicals
  32. 8.6.1 Omicron Biochemicals Company Information
  33. 8.6.2 Omicron Biochemicals Business Overview
  34. 8.6.3 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio
  36. 8.6.5 Omicron Biochemicals Recent Developments
  37. 8.7 Sigma-Aldrich
  38. 8.7.1 Sigma-Aldrich Company Information
  39. 8.7.2 Sigma-Aldrich Business Overview
  40. 8.7.3 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Product Portfolio
  42. 8.7.5 Sigma-Aldrich Recent Developments
  43. 8.8 Toronto Research Chemicals
  44. 8.8.1 Toronto Research Chemicals Company Information
  45. 8.8.2 Toronto Research Chemicals Business Overview
  46. 8.8.3 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio
  48. 8.8.5 Toronto Research Chemicals Recent Developments
  49. 8.9 WITEGA Laboratorien
  50. 8.9.1 WITEGA Laboratorien Company Information
  51. 8.9.2 WITEGA Laboratorien Business Overview
  52. 8.9.3 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Product Portfolio
  54. 8.9.5 WITEGA Laboratorien Recent Developments
  55. 8.10 Thermo Fisher Scientific
  56. 8.10.1 Thermo Fisher Scientific Company Information
  57. 8.10.2 Thermo Fisher Scientific Business Overview
  58. 8.10.3 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product Portfolio
  60. 8.10.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 C13 Stable Isotope Labeled Biomolecules Value Chain Analysis
  2. 9.1.1 C13 Stable Isotope Labeled Biomolecules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 C13 Stable Isotope Labeled Biomolecules Production Mode & Process
  6. 9.2 C13 Stable Isotope Labeled Biomolecules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 C13 Stable Isotope Labeled Biomolecules Distributors
  9. 9.2.3 C13 Stable Isotope Labeled Biomolecules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst